Login
$ARWR
$44.25 +$0.04 (0.09%) After hours

Company Executives

Officer Age In this role Joined Source
Christopher Anzalone Also a director
Chief Executive Officer, President, Director and Board Chair
56 Not stated Not stated
Daniel Apel
Chief Financial Officer
60 Since 2025
1 year
2025
Patrick O’Brien
Chief Operating Officer
62 Since 2022
4 years
2014
James Hamilton
Chief Medical Officer
48 Since 2025
1 year
2014

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Jan 27, 2026 · updated by the 8-K of Jun 16, 2026

Directors
8
serving now
Independent
6 of 6
stated in the proxy; 2 not stated
Average tenure
10.0 years
from year joined
CEO also chairs the board
Yes
Christopher Anzalone
Director Age On board Independent Committees Other public boards 2025 pay Source
Christopher Anzalone
56 2007
19 years
Not stated None stated None stated Paid as CEO
William Waddill
68 2018
8 years
Independent
Audit Committee · Chair Compensation Committee Nomination Committee
Protagonist Therapeutics, Inc., Annexon, Inc. $438,184
Mauro Ferrari
66 2010
16 years
Independent
Science Committee · Chair Audit Committee Nomination Committee
None stated $420,684
Hongbo Lu
55 2024
2 years
Independent
Science Committee Nomination Committee Compensation Committee
Terns Pharmaceuticals, Inc., Zenas Biopharma Inc $420,684
Adeoye Olukotun
81 2020
6 years
Independent
Science Committee · Chair Nomination Committee
Tonix Pharmaceuticals Holding Corp. $420,684
Michael S. Perry
66 2011
15 years
Independent
Compensation Committee · Chair Audit Committee Nomination Committee Science Committee
None stated $428,184
Victoria Vakiener
62 2022
4 years
Independent
Nomination Committee · Chair Audit Committee
None stated $424,434
Matt Cohen Joined Jun 12, 2026
- - - - - -

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

3 disclosed in the proxy filed Jan 27, 2026
Dr. Bruce Given
brother of Dr. Douglass Given, the Company's former Director and Chairman of the Board
$280,000
since August 1, 2025

Consulting arrangement with the Company at a yearly fee, beginning August 1, 2025

Dr. Bruce Given
brother of Dr. Douglass Given, the Company's former Director and Chairman of the Board
$887,227
fiscal year 2025

Base salary, bonus and consulting fees earned, plus 100,000 RSUs awarded in fiscal 2025

Vincent Anzalone
brother of Christopher Anzalone, the Company's Chief Executive Officer, President, Director and Board Chair
$417,568
fiscal year 2025

Employment as Senior Vice President, Investor Relations and Corporate Communications, including base salary, bonus and stock awards

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support